Back to Market返回行情

KRMD KORU Medical Systems, Inc.

USHealthcare
$4.28-3.39%ClosedMarket Cap: $196.6M

As of 2026-07-10 16:00

Why KRMD matters now

KORU Medical Systems, Inc. (KRMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $4.28 with -3.39% on the session and $196.6M in market capitalization; recent performance reads 1-month -1.52% and YTD -32.87%.

The latest financial table shown here is Q1 2026, with revenue of $11.8M, net income of $-807.1K, and EPS of $-0.02. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield 0.1%.

The latest indexable market news headline is "KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress" from Business Wire.

Additional event context on this page matters because analyst consensus is Buy with a median target of $7.50; recent insider activity includes KALBERMATTEN ADAM R filing P-Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

PEG

P/B

10.69

P/S

4.14

EV/EBITDA

-118.49

DCF Value

$-10.67

FCF Yield

0.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

61.5%

Operating Margin

-6.0%

Net Margin

-5.3%

ROE

-13.6%

ROA

-8.0%

ROIC

-12.8%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$11.8M$-807.1K$-0.02
Q4 2025$10.9M$-486.9K$-0.01
FY 2025$41.1M$-2.6M$-0.06
Q3 2025$10.4M$-778.0K$-0.02

Analyst Ratings

Consensus

Buy

Target (Consensus)

$7.50

Target (Median)

$7.50

Target Range

$7.00 - $8.00

Strong Buy: 0Buy: 4Hold: 1Sell: 0Strong Sell: 0
B. Riley SecuritiesBuy
2026-03-13
Canaccord GenuityBuy
2026-03-13
Lake StreetBuy
2025-12-22
Canaccord GenuityBuy
2025-12-17
Piper SandlerNeutral
2025-08-07

Trading Activity

Insider Trades

KALBERMATTEN ADAM Rofficer: President-Chief Commercial Off
Buy2026-06-15
KALBERMATTEN ADAM Rofficer: President-Chief Commercial Off
Buy2026-06-15
Schiller Ericofficer: Chief Technology Officer
Buy2026-05-20
Tharby Linda Mdirector, officer: Chief Executive Officer
Buy2026-05-20
Tharby Linda Mdirector, officer: Chief Executive Officer
Buy2026-05-20

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

0.42

KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.